Merck & Co., Inc. (MRK)
146.95
-0.23
(-0.16%)
USD |
NYSE |
Nov 12, 16:00
146.95
0.00 (0.00%)
Pre-Market: 04:46
Merck Free Cash Flow (Quarterly) : 5.518B for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 5.518B |
| June 30, 2026 | 4.477B |
| March 31, 2026 | 2.927B |
| December 31, 2025 | 1.824B |
| September 30, 2025 | 6.835B |
| June 30, 2025 | 2.529B |
| March 31, 2025 | 1.172B |
| December 31, 2024 | 2.513B |
| September 30, 2024 | 8.508B |
| June 30, 2024 | 4.846B |
| March 31, 2024 | 2.229B |
| December 31, 2023 | -743.00M |
| September 30, 2023 | 6.815B |
| June 30, 2023 | 2.739B |
| March 31, 2023 | 332.00M |
| December 31, 2022 | 3.281B |
| September 30, 2022 | 4.476B |
| June 30, 2022 | 3.173B |
| March 31, 2022 | 3.777B |
| December 31, 2021 | 3.823B |
| September 30, 2021 | 3.625B |
| June 30, 2021 | 1.504B |
| March 31, 2021 | 709.00M |
| December 31, 2020 | 2.575B |
| September 30, 2020 | 728.00M |
| Date | Value |
|---|---|
| June 30, 2020 | 2.80B |
| March 31, 2020 | -279.00M |
| December 31, 2019 | 3.657B |
| September 30, 2019 | 3.267B |
| June 30, 2019 | 2.302B |
| March 31, 2019 | 741.00M |
| December 31, 2018 | 2.663B |
| September 30, 2018 | 2.14B |
| June 30, 2018 | 2.799B |
| March 31, 2018 | 705.00M |
| December 31, 2017 | 3.304B |
| September 30, 2017 | -1.612B |
| June 30, 2017 | 2.924B |
| March 31, 2017 | -53.00M |
| December 31, 2016 | 3.081B |
| September 30, 2016 | 2.562B |
| June 30, 2016 | 1.24B |
| March 31, 2016 | 1.879B |
| December 31, 2015 | 3.754B |
| September 30, 2015 | 2.989B |
| June 30, 2015 | 2.314B |
| March 31, 2015 | 2.081B |
| December 31, 2014 | -1.654B |
| September 30, 2014 | 4.028B |
| June 30, 2014 | 2.013B |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Johnson & Johnson | 5.363B |
| Eli Lilly & Co. | 4.157B |
| Pfizer Inc. | 4.802B |
| Bristol Myers Squibb Co. | 3.837B |
| Abbott Laboratories | 1.224B |